Skip to main content

Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.